Spoor Johan M.'s Form 4/A amendment
AmendedPerspective Therapeutics, Inc. (CATX) · filed Dec 4, 2024
- Accession no.
- 0000950170-24-133347
- Filed
- Dec 4, 2024
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 26, 2024
This filing lists no transactions. It carries over 3 transactions from the original filing that it did not restate. Open-market purchases total $100.4K.
This amendment restates part of 0000950170-24-130754 (filed Nov 26, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spoor Johan M.CIK 0001535289 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000950170-24-130754 (filed Nov 26, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Common Stock | PPurchaseAcquired | +14,500 | $3.78F1 | +$54,810 | 152,072 | Direct | |
| Nov 25, 2024 | Common Stock | PPurchaseAcquired | +5,400 | $3.80 | +$20,520 | 5,400 | Indirect | |
| Nov 25, 2024 | Common Stock | PPurchaseAcquired | +6,600 | $3.80 | +$25,080 | 66,600 | Indirect |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.645 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Beneficial ownership was reported to be 152,072 and should have been reported as 28,257.
- F2
Indirect beneficial ownership was reported to be 66,600 and should have been reported as 12,600.
- F3
Indirect beneficial ownership was reported to be 10,000 and should have been reported as 1,000.
Remarks
This Form 4/A is being filed to correct certain previously reported information regarding the beneficial ownership of the Reporting Person as reflected in the original Form 4 filed on November 26, 2024 (the "Original Form 4"). Certain amounts reported in the Original Form 4 did not reflect the 1-for-10 reverse stock split effected by the Issuer in June 2024; such amounts have been updated accordingly herein.